ASHLEIGH HAYTON: Open Payments
NPI 1477164937 · MARTIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 13 payments from 9 companies in 2025. Trend: 2023 $140 · 2024 $143 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| KYOWA KIRIN, INC. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Verona Pharma, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: CAPLYTA, GVOKE HYPOPEN, CRYSVITA, JOURNAVX, NURTEC ODT, Wegovy, Ohtuvayre, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
